A study to determine tumor DNA, tumor-derived DNA from multiple metastatic sites, genetic evolution of tumors and analyzing TKI resistance
Latest Information Update: 09 Jul 2021
At a glance
- Drugs Alectinib (Primary) ; Brigatinib (Primary) ; Ceritinib (Primary) ; Crizotinib (Primary) ; Ensartinib (Primary) ; Lorlatinib (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Pharmacodynamics
- 09 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology